Review

The Role of Finasteride in the Management of Androgenetic Alopecia in Male: A Narrative Review

Anil Tumkur1★, Charmine Caryn Teo Cher Ern1, Chang Ching Shuang1, Amilia Chai Hui Yong1, Chan Poh Yee1, Chai Tze Leen1, Lee Kah Lock1, Nermesh Singh1★ Corresponding author

  1. 1School of Pharmacy, International Medical University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur, MALAYSIA.

CORRESPONDENCE

Anil Tumkur

School of Pharmacy, International Medical University, Jalan Jalil Perkasa 19, Bukit Jalil, Kuala Lumpur, MALAYSIA.

pharmacistanil@gmail.com

Volume 13, Issue 1 · pp. 3–13 · PUBLISHED · DOI: 10.5530/ijopp.13.1.2

View on IJPP original site ↗

ABSTRACT

The purpose of this review was to evaluate the role of finasteride, a type-II 5α-reductase inhibitor in the prevention and treatment of androgenetic alopecia (AGA) in males. Finasteride inhibits 5α-reductase and reduce the biosynthesis of dihydrotestosterone (DHT). This inhibition marks a decrease in concentration of DHT and provides a novel and selective approach to androgen deprivation. Clinical trials have proven the safety and efficacy of tablet finasteride 1 mg for AGA. In this review, we discuss all aspects of finasteride, including dosing and indication, pharmacology, pharmacokinetics to its role in the treatment of AGA.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Tumkur, A., Ern, C. C. T. C., Shuang, C. C., Yong, A. C. H., Yee, C. P., Leen, C. T., Lock, L. K., & Singh, N. (). The Role of Finasteride in the Management of Androgenetic Alopecia in Male: A Narrative Review. Indian Journal of Pharmacy Practice, 13(1), 3–13. https://doi.org/10.5530/ijopp.13.1.2